These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9397178)

  • 21. cycloSal-Pronucleotides of 2'-fluoro-ara- and 2'-fluoro-ribo-2',3'- dideoxyadenosine as a strategy to bypass a metabolic blockade.
    Meier C; Knispel T; Marquez VE; Siddiqui MA; De Clercq E; Balzarini J
    J Med Chem; 1999 May; 42(9):1615-24. PubMed ID: 10229630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular metabolism of beta-L-2',3'-dideoxyadenosine: relevance to its limited antiviral activity.
    Placidi L; Cretton-Scott E; Gosselin G; Pierra C; Schinazi RF; Imbach JL; el Kouni MH; Sommadossi JP
    Antimicrob Agents Chemother; 2000 Apr; 44(4):853-8. PubMed ID: 10722481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives.
    McGuigan C; Hassan-Abdallah A; Srinivasan S; Wang Y; Siddiqui A; Daluge SM; Gudmundsson KS; Zhou H; McLean EW; Peckham JP; Burnette TC; Marr H; Hazen R; Condreay LD; Johnson L; Balzarini J
    J Med Chem; 2006 Nov; 49(24):7215-26. PubMed ID: 17125274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity.
    Cooney DA; Ahluwalia G; Mitsuya H; Fridland A; Johnson M; Hao Z; Dalal M; Balzarini J; Broder S; Johns DG
    Biochem Pharmacol; 1987 Jun; 36(11):1765-8. PubMed ID: 3107569
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase.
    Shi J; McAtee JJ; Schlueter Wirtz S; Tharnish P; Juodawlkis A; Liotta DC; Schinazi RF
    J Med Chem; 1999 Mar; 42(5):859-67. PubMed ID: 10072683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and in vitro antiviral activity evaluation of 9-(2-azido-2,3-dideoxy-beta-D-threo-pentofuranosyl)adenine derivatives.
    Takamatsu S; Izawa K; Maruyama T; Katayama S; Hirose N; De Clercq E
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1053-7. PubMed ID: 11562957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unnatural enantiomers of 5-azacytidine analogues: syntheses and enzymatic properties.
    Gaubert G; Gosselin G; Eriksson S; Vita A; Maury G
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):837-40. PubMed ID: 11563127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphoramidate protides of 2',3'-dideoxy-3'-fluoroadenosine and related nucleosides with potent activity against HIV and HBV.
    Gudmundsson KS; Daluge SM; Johnson LC; Jansen R; Hazen R; Condreay LD; McGuigan C
    Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1953-61. PubMed ID: 14609234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclopropyl and related analogs of the anti-HIV compound, isodideoxyadenosine.
    Nair V; Mickle T; Bera S
    Nucleosides Nucleotides Nucleic Acids; 2003 Mar; 22(3):239-47. PubMed ID: 12816383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unnatural enantiomers of 5-azacytidine analogues: syntheses and enzymatic properties.
    Gaubert G; Mathé C; Imbach J; Eriksson S; Vincenzetti S; Salvatori D; Vita A; Maury G
    Eur J Med Chem; 2000 Nov; 35(11):1011-9. PubMed ID: 11137229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication.
    Eldrup AB; Prhavc M; Brooks J; Bhat B; Prakash TP; Song Q; Bera S; Bhat N; Dande P; Cook PD; Bennett CF; Carroll SS; Ball RG; Bosserman M; Burlein C; Colwell LF; Fay JF; Flores OA; Getty K; LaFemina RL; Leone J; MacCoss M; McMasters DR; Tomassini JE; Von Langen D; Wolanski B; Olsen DB
    J Med Chem; 2004 Oct; 47(21):5284-97. PubMed ID: 15456273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus.
    Balzarini J; Baba M; Pauwels R; Herdewijn P; Wood SG; Robins MJ; de Clercq E
    Mol Pharmacol; 1988 Mar; 33(3):243-9. PubMed ID: 3258404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 3. 6-Amino prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine.
    Driscoll JS; Siddiqui MA; Ford H; Kelley JA; Roth JS; Mitsuya H; Tanaka M; Marquez VE
    J Med Chem; 1996 Apr; 39(8):1619-25. PubMed ID: 8648601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of beta-D-pentofuranonucleoside derivatives of 2-azidoadenine and 6-azidopurines.
    Mathé C; Lioux T; Gosselin G
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):605-9. PubMed ID: 14565237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine deaminase activity in human diploid skin fibroblasts varies with the age of the donor.
    Murphy E; Holland MJ; Cox RP
    J Med; 1978; 9(3):237-44. PubMed ID: 105069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the DNA incorporation in human MOLT-4 cells of two 2'-beta-fluoronucleosides, 2'-beta-fluoro-2',3'-dideoxyadenosine and fialuridine.
    Ahluwalia GS; Driscoll JS; Ford H; Johns DG
    J Pharm Sci; 1996 Apr; 85(4):454-5. PubMed ID: 8901088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI.
    Koudriakova T; Manouilov KK; Shanmuganathan K; Kotra LP; Boudinot FD; Cretton-Scott E; Sommadossi JP; Schinazi RF; Chu CK
    J Med Chem; 1996 Nov; 39(23):4676-81. PubMed ID: 8917656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacies of beta-L-D4A against Hepatitis B virus in 2.2.15 cells.
    Gao LL; Wang XY; Lin JS; Zhang YH; Li Y
    World J Gastroenterol; 2008 Feb; 14(8):1263-7. PubMed ID: 18300355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, anti-HIV activity, and molecular mechanism of drug resistance of L-2',3'-didehydro-2',3'-dideoxy-2'-fluoro-4'-thionucleosides.
    Choo H; Chong Y; Choi Y; Mathew J; Schinazi RF; Chu CK
    J Med Chem; 2003 Jan; 46(3):389-98. PubMed ID: 12540238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chiral discrimination of 2'-deoxy-L-cytidine and L-nucleotides by mouse deoxycytidine kinase: low stereospecificities for substrates and effectors.
    Tomikawa A; Kohgo S; Ikezawa H; Iwanami N; Shudo K; Kawaguchi T; Saneyoshi M; Yamaguchi T
    Biochem Biophys Res Commun; 1997 Oct; 239(1):329-33. PubMed ID: 9345319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.